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Background: Over the last decade, nanotechnology has provided researchers with new 
  nanometer materials, such as nanoparticles, which have the potential to provide new therapies 
for many lung diseases. In this study, we investigated the acute effects of polystyrene nanopar-
ticles on epithelial ion channel function.
Methods: Human submucosal Calu-3 cells that express cystic fibrosis transmembrane con-
ductance regulator (CFTR) and baby hamster kidney cells engineered to express the wild-type 
CFTR gene were used to investigate the actions of negatively charged 20 nm polystyrene 
nanoparticles on short-circuit current in Calu-3 cells by Ussing chamber and single CFTR Cl- 
channels alone and in the presence of known CFTR channel activators by using baby hamster 
kidney cell patches.
Results: Polystyrene nanoparticles caused sustained, repeatable, and concentration-dependent 
increases in short-circuit current. In turn, these short-circuit current responses were found to 
be biphasic in nature, ie, an initial peak followed by a plateau. EC50 values for peak and plateau 
short-circuit current responses were 1457 and 315.5 ng/mL, respectively. Short-circuit cur-
rent was inhibited by diphenylamine-2-carboxylate, a CFTR Cl- channel blocker. Polystyrene 
nanoparticles activated basolateral K+ channels and affected Cl- and HCO3
- secretion. The 
mechanism of short-circuit current activation by polystyrene nanoparticles was found to be 
largely dependent on calcium-dependent and cyclic nucleotide-dependent phosphorylation of 
CFTR Cl- channels. Recordings from isolated inside-out patches using baby hamster kidney 
cells confirmed the direct activation of CFTR Cl- channels by the nanoparticles.
Conclusion: This is the first study to identify the activation of ion channels in airway cells 
after exposure to polystyrene-based nanomaterials. Thus, polystyrene nanoparticles cannot be 
considered as a simple neutral vehicle for drug delivery for the treatment of lung diseases, due 
to the fact that they may have the ability to affect epithelial cell function and physiological 
processes on their own.
Keywords: CFTR, cystic fibrosis transmembrane conductance regulator, ion channels, 
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Introduction
Cystic fibrosis is an inheritable disease caused by a mutation in the cystic fibrosis 
  transmembrane conductance regulator (CFTR) gene located on chromosome 7.1 The cftr 
gene encodes a cAMP-regulated Cl- channel, CFTR, located on the apical membrane of 
epithelial cells.2 Structural analysis of the CFTR protein shows that it consists of a 1480 
amino acid backbone containing two nucleotide-binding domains, 12 transmembrane 
domains, and a unique cytoplasmic regulatory domain.3 Phosphorylation of the regula-
tory domain by cAMP-dependent protein kinase A is a   prerequisite for channel opening.4 International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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ATP-induced   dimerization of nucleotide-binding domains 
also plays an important role in this process.5
There are over 1800 recognized mutations of the cftr gene 
which give rise to the disease known as cystic fibrosis.6 Lung 
disease in cystic fibrosis patients is the principal cause of 
morbidity and mortality associated with the condition, and 
is characterized by impaired mucus clearance due to altered 
ion transport by airway epithelial cells.7 Submucosal glands 
of the respiratory system have been proposed as the primary 
site for the pathology of cystic fibrosis lung disease.8 CFTR 
Cl- channels located on the apical membrane of lung epi-
thelial cells are involved in the regulation of physiological 
processes, such as cell volume control and transepithelial 
fluid transport, as well as modulating the function of other 
ion channels, eg, epithelial Na+ channels, outwardly rectify-
ing Cl- channels, and K+ channels, and thus the transport of 
Na+, K+ and Cl- ions, and H2O.9
Nanotechnology is providing science with a new platform 
in medicine which has the potential to provide disciplines 
such as diagnostics and clinical medicine, as well as basic 
research, with new materials in the nanometer range that 
have many far reaching applications. Nanomaterials, such 
as nanoparticles, differ from other materials due to a number 
of special characteristics, including small particle size, large 
surface area, shape, chemical composition, and charge.10 
Together these characteristics give nanoparticles numerous 
advantages over other delivery systems, and the targeted 
delivery of drugs using nanocarriers for the treatment of 
respiratory diseases is a major focus of interest.10 Many 
approaches have been undertaken for the delivery of nano-
structures, such as micelles, liposomes, and nanoparticles 
to the lungs via the use of nebulization for suspensions and 
dry powder carriers.10
In 2007, Yacobi et al investigated the effects of ultrafine 
ambient particulate suspensions, polystyrene nanoparticles, 
quantum dots, and single-walled carbon nanotubes on 
transmonolayer resistance (Rt) and equivalent short-circuit 
current on rat alveolar cell epithelia monolayers. They found 
that Rt was reduced after apical exposure of rat alveolar cell 
epithelia monolayers to a variety of nanomaterials, includ-
ing ultrafine ambient particulate suspensions, positively 
charged quantum dots, and single-walled carbon nanotubes 
at varying concentrations.11 In turn, other research groups 
have investigated the interaction of silver nanoparticles on 
voltage-activated Na+ currents in hippocampal CA1 neurons, 
with results indicating that silver nanoparticles may alter the 
action potential of these neurons by reducing voltage-gated 
sodium currents.12
Even though there have been many advances in the area 
of bionanoscience, there is still very little known about the 
complex interaction of nanoparticles with the cell membrane 
on airway epithelial cells, and the effect that this interaction 
can have on many diverse cellular processes. Nanoparticles at 
the cell membrane have the potential to interact with numer-
ous cell signaling receptors, ion channels, transporters, and 
cytoskeleton machinery which work to control and regulate 
basic cellular and physiological processes. Recent studies 
have shown that gold nanoparticles coated with antibodies 
have the ability to alter signaling processes and regulate 
membrane receptor internalization in human breast cancer 
cells.13 Furthermore, titanium dioxide nanoparticles, upon 
contact with BEAS-2B human bronchial cells, can induce 
programmed cell death via the mitochondrial apoptosis 
pathway.14
Taken together, our research group was interested in 
studying the interactions of nanoparticles with ion channels 
in human airway epithelial cells, with a specific focus on 
the CFTR Cl- channel. We hypothesized that nanoparticles 
could modulate epithelial ion channel function. To this end, 
we wanted to investigate if nanoparticles could affect api-
cally located CFTR Cl- channels and/or other ion channels 
(basolateral K+ channels) and cotransporters, either directly 
or indirectly. To test this hypothesis, we used commercially 
available 20 nm negatively charged polystyrene nanoparticles 
(N20). We chose to use polystyrene nanoparticles because 
this specific type of nanoparticle is being increasingly 
characterized for use in nanosensors and drug nanocarrier 
investigations.15,16 Polystyrene nanoparticles have also been 
shown to interact with proteins to form a “protein corona” 
upon interaction with biological fluids,17 and more recently 
studies by Salomon and Ehrhardt have found that polysty-
rene nanoparticles can affect the function of P glycoprotein/
MDR1 membrane transporters in A549 human alveolar 
epithelial cells.18
We used the Ussing chamber technique to study the 
effects of N20 on ion fluxes in human airway submucosal 
cells, ie, Calu-3. Any findings with the Ussing chamber were 
then verified with the single channel patch clamp technique 
using baby hamster kidney cells stably transfected with a 
wild-type CFTR Cl- channel. We discovered that acute apical 
exposure of lung epithelial cells to N20 promoted transepi-
thelial ion transport, affecting not only apically located CFTR 
Cl- channels but also basolateral K+ channels. The mechanism 
of short-circuit current activation by nanoparticles was found 
to be mainly dependent on calcium-dependent and cyclic 
nucleotide-dependent phosphorylation of CFTR Cl- channels. International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Our patch clamp data reveal an exciting new phenomenon 
that nanoparticles can interact and activate CFTR Cl- chan-
nels directly. No other study to our knowledge has shown 
the direct activation of airway ion channels by polystyrene 
nanoparticles.
Materials and methods
Chemicals
Polystyrene latex beads were purchased from Invitrogen 
(carboxyl-modified 20 nm, F-8787; Carlsbad, CA) and core-
labeled with fluorophore according to the manufacturer’s 
specifications. Before all experiments, test solutions of 
polystyrene nanoparticles were dispersed using a sonicator 
(8890-MTH; Cole–Parmer, Vernon Hills, IL) to prevent 
aggregation. Forskolin (10 mM; LC Laboratories, Woburn, 
MA) was made as a 1000-fold stock solution in ethanol. 
Diphenylamine-2-carboxylate 1 M was dissolved in dim-
ethyl sulfoxide and was prepared fresh for each experiment. 
Furosemide 100 mM was sourced from Sigma-Aldrich 
(St Louis, MO) and was dissolved in distilled H2O with one 
drop of concentrated NaOH 5 N. XE991 (10 mM) was a 
generous gift from Dr BS Brown (DuPont, Wilmington, DE) 
and was dissolved in HCl 0.1 N. Nystatin was prepared as a 
180 mg/mL stock solution in dimethyl sulfoxide and soni-
cated for 30 seconds just before use. Clotrimazole 30 mL was 
sourced from Sigma-Aldrich and was made as a 1000-fold 
stock solution in ethanol. Carbachol 100 mM and S-nitroso-
glutathione 100 mM were purchased from Sigma-Aldrich 
and dissolved in distilled H2O. NG-nitro-L-arginine methyl 
ester (L-NAME) 100 mM was purchased from Alexis Bio-
chemicals (San Diego, CA). 1H-[1, 2, 4] oxadiazolol-[4, 3-a] 
quinoxalin-1-one (ODQ, 10 mM; Tocris Cookson, St Louis, 
MO) and thapsigargin 1 mM (Sigma-Aldrich) were prepared 
as 1000-fold stock solutions in dimethyl sulfoxide. All other 
items were purchased from Sigma-Aldrich.
Cell lines and culture
A Calu-3 cell line was obtained from the American Type 
Culture Collection (ATCC HBT-55) and maintained as a 
monolayer culture in plastic T-75 cm2 tissue culture flasks. 
The cells were grown in Dulbecco’s Modified Eagle’s 
Medium, a low glucose media 1 g/L also containing sodium 
pyruvate 110 mg/L and supplemented with 10% fetal bovine 
serum, gentamicin sulfate 5 µg/mL, penicillin G 6 µg/mL, 
and streptomycin 10 µg/mL. Cells were maintained at 37°C 
in a humidified atmosphere of 95% O2 and 5% CO2. When 
confluent, the cell line was detached enzymatically with 
trypsin-ethylenediamine tetra-acetic acid and subcultured 
into a new cell culture flask. The medium was replaced every 
2 days. Cells were used for experiments between passages 
21–45. For transepithelial measurements, Calu-3 cells were 
seeded at a density of 2 × 105 cells/cm2 onto SnapwellTM 
inserts (0.45 µm, 1 cm2; Corning, Cambridge, MA). For the 
first 7 days, cells were grown in liquid-covered culture, with 
the basolateral and apical media being changed every 2 days 
(2 mL media basolaterally, 500 µL apically). After day 7, 
from initial seeding on Snapwell inserts, all cells were grown 
using air interface culturing in which medium was added only 
to the basolateral side of the inserts (2 mL). Cells were used 
in transepithelial experiments on days 12–22.
size and zeta potential determination  
for polystyrene nanoparticles
The size and zeta potential for N20 was determined using a 
Zetasizer Nano ZS (Malvern Instruments, Worcestershire, 
UK). Zeta potential and size was measured at 37°C, three 
repeats per sample. Polystyrene nanoparticles were diluted in 
Krebs–Henseleit solution containing (in mM): NaCl, 116.4; 
KCl, 4.7; CaCl2, 1.8; MgCl2, 1.2; NaH2PO4, 0.78; NaHCO3, 
25.0; and 10 glucose (pH was 7.4 ± 0.1 when bubbled with 
95% O2 and 5% CO2). Measurements were conducted using 
a concentration of 100 µg/mL. The dielectric constant of the 
dispersant was set at 78.5, viscosity as for water at 0.8872 cP, 
and refractive index at 1.333.
Cytotoxicity
Lactate dehydrogenase assay and polystyrene 
nanoparticles
To evaluate the cytotoxicity of N20 alone on Calu-3 cells, 
104 × cells/100 µL of cell culture medium were plated 
into 96-well round-bottom plates, and the lactate dehy-
drogenase assay was performed. Extracellular lactate 
dehydrogenase release was measured using a colorimetric 
CytoTox 96® nonradioactive cytotoxicity assay kit from 
Promega   (Madison, WI) following the manufacturer’s 
instructions, with absorbance recorded at 492 nm (FLUO-
star, OPTIMA; BMG Labtech, Offenburg, Germany). N20 
was diluted in serum-free medium and was added to cells 
(in triplicate) at concentrations of 1, 10, 25, 50, 100, and 
200 µg/mL. Cell survival was determined 24 hours post-
treatment with N20 by the lactate dehydrogenase assay 
described above. To determine the percentage cytotoxicity, 
the average absorbance of the triplicate was calculated. As 
control, extracellular release of lactate dehydrogenase was 
obtained from unexposed cells (low control), and maximum 
release of lactate dehydrogenase was obtained by lysis of cells International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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with the supplied lysis buffer (high control). The following 
equation was applied to the experimental values obtained: 
percent cytotoxicity = release of lactate dehydrogenase from 
exposed cells – release of lactate dehydrogenase (low con-
trol)/release of lactate dehydrogenase (high control) – release 
of lactate dehydrogenase (low control) × 100.
MTT assay and polystyrene nanoparticles
Cytotoxicity was measured using a CellTiter 96® non-
radioactive cell proliferation assay kit from Promega fol-
lowing the manufacturer’s instructions. Calu-3 cells were 
seeded in triplicate at a density of 104 × cells/100 µL of 
cell culture medium into 96-well plates. The following day, 
Calu-3 cells were treated with N20 under serum-free condi-
tions at the following concentrations; 1, 10, 25, 50, 100, and 
200 µg/mL for 24 hours. The 3-(4,5-dimethyl-thiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay evaluates 
mitochondrial activity (cell growth and cell death) and is 
performed by adding a premixed optimized dye solution to 
culture wells. Absorbance is recorded at 570 nm (FLUOstar). 
The recorded absorbance is directly proportional to the 
number of live cells. To determine the percentage cytotox-
icity, the average of the triplicates was calculated for each 
concentration tested. Results were calculated as a percent-
age of the control values (unexposed cells), where percent 
  cytotoxicity = (experimental abs570 nm of exposed cells/abs570 nm 
of unexposed cells) ×100.
Transepithelial measurements
Ussing chamber studies were carried out using the apparatus 
and methods described by Duta et al19 and Duszyk.20 Prior 
to use in transepithelial measurement studies, all Calu-3 cell 
inserts were fed with complete fresh media for 1 hour and 
were washed for 30 minutes in Krebs–Henseleit solution 
(2 mL basolaterally, 500 µL apically). Calu-3 cell mono-
layers were grown on Snapwell inserts for at least 12 days 
prior to mounting into modified Ussing chambers. The cell 
monolayers were bathed at a temperature of 37°C in Krebs–
Henseleit solution. Chemicals were added from concentrated 
stocks and all chambers were continuously mixed by bubbling 
the Krebs–Henseleit solution with 95% O2 and 5% CO2 to 
maintain a constant pH of 7.4. The transepithelial potential 
difference was clamped to zero using a DVC 1000 voltage/
current amplifier (World Precision Instruments, Sarasota, 
FL), and the resulting short-circuit current was recorded 
by Ag-AgCl2 electrodes, using 3 M KCl agar bridges. The 
short-circuit current was allowed to stabilize for up to 
approximately 10 minutes or more before the application of 
nanoparticles or other tested chemicals. Nanoparticles were 
always added apically. The transepithelial resistance was 
calculated using Ohm’s law, by measuring current changes 
in response to 0.5 mV pulses.
Basolateral membrane K+ currents
The effects of the nanoparticles on basolateral membrane K+ 
channels were measured after permeabilization of the apical 
membrane with nystatin 180 µg/mL and establishment of an 
apical-to-basolateral K+ concentration gradient. Apical NaCl 
was replaced by equimolar amounts of potassium gluconate 
and basolateral NaCl with sodium gluconate. The concen-
tration of calcium gluconate was increased from 2.5 mM 
to 5 mM. Under such conditions, the contribution of apical 
Cl- channels to the short-circuit current is eliminated and 
the measured short-circuit current represents K+ currents as 
these ions move down the concentration gradient through 
basolateral K+ channels.
Anion substitution studies
hCO3
- free transepithelial measurements  
and polystyrene nanoparticles
The effects of nanoparticles on the short-circuit current were 
assessed in the absence of bicarbonate ions. A bicarbonate-
free Krebs–Henseleit solution was used with apical and 
basolateral HCO3
- ions exchanged for HEPES 10 mM. The 
overall pH was adjusted to 7.4 and the solutions were mixed 
with O2.
Low Cl- transepithelial measurement and 
polystyrene nanoparticles
The effects of nanoparticles on the short-circuit current were 
measured under low chloride conditions. A low chloride 
Krebs–Henseleit solution was used with apical and basolat-
eral NaCl being exchanged for sodium gluconate 116 mM 
and KCl for potassium gluconate 4.7 mM. The concentration 
of calcium gluconate was increased to 5 mM to compensate 
for the Ca2+-buffering capacity of the gluconate.
Patch clamp experiments
These experiments were carried out using baby hamster 
kidney cells stably transfected with wild-type human CFTR, 
as previously described.21 The experiments were performed 
in the excised, inside-out configuration of the patch clamp 
technique. In all experiments, the pipette solution contained 
(in mM) sodium gluconate 150, MgCl2 2, and HEPES 10, 
and the bath solution NaCl 150, MgCl2 2, and HEPES 10. 
All solutions were adjusted to pH 7.4 with NaOH 5 N. International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1347
Polystyrene nanoparticles stimulate airway ion channels
The membrane potential was held at 0 mV and the junction 
potential was compensated. Following patch excision, chan-
nel activity was assessed by the addition of N20 50 µg/mL 
to the bath solution. Controls (untransfected baby hamster 
kidney cell patches) were treated with N20 50 µg/mL, as 
described earlier. This concentration was chosen based on 
Ussing chamber studies showing that N20 50 µg/mL resulted 
in maximal stimulation of transepithelial anion fluxes. In the 
second set of experiments, the patch excision was exposed 
to N20, as already discussed, in the presence of a 10–20 nM 
protein kinase as a catalytic subunit and MgATP 0.2 to 1 mM 
in the bath. Au(CN)2 500 µM was used as a blocker of the 
CFTR channel. Patch clamp recordings were analyzed by the 
Clampfit program, and open probability (Po) was calculated 
using standard techniques.
Data analysis
Nanoparticle concentration-response was fitted with the 
following equation:
  Y =   bottom + (top-bottom)/(1 + 10 ^ [(LogEC50-X) 
× Hill Slope])   (1)
The data points show the mean ± the standard error of 
the mean. The short-circuit current is expressed in units 
of µA/cm2. All data are presented as group means ± standard 
error of the mean for the individual experiments. Statistical 
analysis of the mean difference between multiple groups was 
determined by one-way analysis of variance, followed by 
Bonferroni post hoc tests or between two groups by paired/
unpaired t-tests as appropriate. A P value of ,0.05 was 
considered statistically significant. All statistical analyses 
were performed using GraphPad Prism (v 5.00 for Windows; 
GraphPad Software, San Diego, CA).
Results
Nanoparticle characterization
N20 nanoparticles according to manufacturer’s specifica-
tions were 20 nm in size and negatively charged. Our own 
measurements have shown that N20 had a Z average (nm) 
of 45.2 ± 0.01, a zeta potential of -15.1 ± 0.8 mV, and a 
polydispersity index of 0.22 ± 0.002 in Krebs–Henseleit 
solution. Furthermore, our lactate dehydrogenase cyto-
toxicity studies showed that N20 1–200 µg/mL did not 
exert any cytotoxic effects on Calu-3 cells for up to 
24 hours (n = 4, data not shown). Also, we did not observe 
any significant changes in Calu-3 cell viability by MTT 
analysis after cells were exposed to N20 1–200 µg/mL 
over a 24-hour period (cell viability at the highest con-
centration of N20 tested was 92.5% ± 5.7% vs control, 
P . 0.05, n = 3).
Nanoparticles activate anion secretion  
in Calu-3 cells
Acute apical exposure of Calu-3 cells to N20 activated the 
short-circuit current in a concentration-dependent manner. 
Figure 1 shows the fitting of equation (1) to the experimen-
tal data. The current activated by N20 showed a biphasic 
response, ie, an initial peak followed by a plateau. Both peak 
and plateau values were used to determine the EC50 and Hill 
coefficient (Figures 1A and 1B,) with both values working 
at low concentrations (1457 ng/mL for peak short-circuit 
current and 315.5 ng/mL for plateau short-circuit current, 
respectively). Therefore, in our remaining anion transport 
studies, plateau and peak short-circuit current values are 
reported where appropriate to determine the effect of N20 
on the short-circuit current.
Apically located CFTR Cl- channels serve as the primary 
conductive pathway for anion secretion in Calu-3 cells and 
are the main contributors to the short-circuit current in 
transepithelial studies. To determine the mechanism(s) of 
action of nanoparticles on short-circuit current activation, a 
number of pharmacological agents were used to probe the 
actions of nanoparticles on ion channels. N20 10 µg/mL 
increased short-circuit current by 12.4 ± 0.4 µA/cm2 (pla-
teau Isc, Figure 2A). The subsequent addition of forskolin, 
an activator of adenylyl cyclase (10 µM), further increased 
the short-circuit current by 15.8 ± 2.9 µA/cm2 (plateau Isc, 
Figure 2A) and this effect was blocked by diphenylamine-2-
carboxylate, a blocker of CFTR (1 mM).22 In the absence of 
nanoparticles, forskolin activated the short-circuit current by 
16.2 ± 1.0 µA/cm2 (plateau Isc, Figure 2B). However, the sub-
sequent addition of N20 after forskolin resulted in a signifi-
cantly lower short-circuit current response (4.7 ± 2.4 µA/cm2) 
when compared with control responses (P , 0.05, n = 3, 
Figure 2B), showing that there is in fact an overlap between 
the mechanism of short-circuit current activation by N20 and 
forskolin. A summary of the statistical analysis of Figures 2A 
and 2B is shown in Figure 2D.
As shown on Figure 2C, diphenylamine-2-carbox-
ylate 1 mM reduced the basal short-circuit current by 
9.2 ± 1.6 µA/cm2 prior to the addition of N20 10 µg/mL. 
However, this pretreatment with diphenylamine-2-carbox-
ylate only partially inhibited the activation of short-circuit 
current by N20 (5.0 ± 2.3 µA/cm2) when compared with 
control responses of 28.72 ± 3.5 µA/cm2 (peak Isc, P , 0.05, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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unpaired t-test, n = 3, Figure 2C). Furosemide, a blocker of 
the NKCC cotransporter located on the basolateral mem-
brane, exerted little effect on inhibition of the short-circuit 
current caused by N20 in the presence of diphenylamine-2-
carboxylate (Figure 2C).
Nanoparticles activate K+ channels  
in Calu-3 cells
Observations made in previous experiments (Figure 2C) 
which showed that N20 was capable of increasing the 
short-circuit current in the presence of a blocked CFTR and 
also that furosemide had minimal effect on the blocking of 
short-  circuit current in the presence of diphenylamine-2-
  carboxylate, suggested that N20 in addition to CFTR has other 
ion channel and/or cotransporter targets. Thus, we began to 
investigate the interactions between basolateral K+ channels 
and nanoparticles, because these channels can also act as a 
driving force for anion secretion in Calu-3 cells.
Nystatin was used to permeabilize the apical mem-
brane in the presence of an established transepithelial 
ion gradient to measure K+ currents. In our experiments, 
permeabilization of the apical membrane with nystatin 
180 µg/mL led to an increase in the short-circuit current 
of 97.3 ± 13.4 µA/cm2. N20 10 µg/mL apical, activated 
K+ current in Calu-3 cells by a further 56.2 ± 6.7 µA/cm2 
(Figure 3A). The activation of K+ currents by N20 was 
inhibited by XE991, a potent and selective inhibitor of 
K+ channels,23 with an average reduction in the short-circuit 
current of 57.6 ± 9.0 µA/cm2.
To investigate if this effect of nanoparticles on 
K+ channels was cAMP-dependent, Calu-3 cells were 
pretreated with forskolin 10 µM both sides. Forskolin 
increased the short-circuit current by 39.3 ± 9.2 µA/cm2 
and abolished the effects of N20 10 µg/mL on K+ currents 
(Figure 3B). Moreover, forskolin-induced activation of 
K+ channels was XE991-sensitive, decreasing the short-
circuit current by 114.2 ± 17.6 µA/cm2, thus again show-
ing that N20 activates K+ currents in a cAMP-dependent 
manner (Figure 3B). Further confirmation that N20 acts 
through the cAMP-pathway came from data showing that 
N20-activated K+ currents in Calu-3 cells were not sensi-
tive to clotrimazole, a known inhibitor of Ca2+-regulated 
K+ channels (Figure 3C).
Anion substitution studies
In airway epithelial cells such as Calu-3, the primary baso-
lateral entry pathways for Cl- and HCO3
- anions are through 
the NKCC and Na+-HCO3
- cotransporters, respectively. 
Both anions have been shown to leave the cell via CFTR 
Cl- channels. We wanted to examine if either one of these 
two anions (Cl- or HCO3
-) is preferentially secreted by 
Calu-3 cells upon stimulation by N20. In these experiments, 
we decided to use forskolin short-circuit current responses 
as a point for comparison with N20-induced short-circuit 
current responses.
When we compared the responses of forskolin and N20 on 
the short-circuit current in normal Krebs–Henseleit solution, 
we found no significant differences between their stimula-
tion of short-circuit current; 36.3 ± 1.5 vs 29.8 ± 4.8 µA/
cm2, respectively (peak Isc, P . 0.05, n = 3). However, when 
we compared the response of N20 (11.7 ± 2.0 µA/cm2) on 
short-circuit current under conditions free of HCO3
- with that 
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of forskolin (35.7 ± 8.8 µA/cm2) under the same conditions, 
we found a significant decrease in N20-induced short-circuit 
current responses (peak Isc, P , 0.05, n = 4). Similarly, we 
observed a reduction in N20-induced short-circuit current 
responses under low Cl- conditions (26.1 ± 3.5 µA/cm2) when 
compared with forskolin (58.8 ± 0.7 µA/cm2, peak Isc, P , 0.05, 
n = 4). A summary of these results is shown in Figure 4. In 
all experiments, the addition of diphenylamine-2-carboxylate 
1 mM apical reduced the activated short-circuit current to 
baseline levels (data not shown).
For each set of experiments carried out using either 
normal KH, HCO3
- free, or low Cl- solutions, the ratio for 
the N20-activated short-circuit current as a factor of the 
forskolin-activated short-circuit current was calculated (N20-
induced short-circuit current/forskolin induced short-circuit 
current). The ratio value under normal Krebs–Henseleit 
solution conditions was found to be 0.82 ± 0.1. The ratio 
value we obtained under HCO3
- free and low Cl- conditions 
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Figure 2 The effect of N20 on transepithelial anion secretion in Calu-3 cells. A) Activation of the short-circuit current by N20 10 µg/mL apical. Forskolin 10 µM both sides 
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Note: *P , 0.05 (n = 3, one-way analysis of variance).
was 0.32 ± 0.06 and 0.42 ± 0.08, respectively. Therefore, 
N20-induced short-circuit current responses are dependent 
on both HCO3
- and Cl- transport by airway cells.
Nanoparticles affect Ca2+-mediated anion 
secretion in Calu-3 cells
In these studies, we used carbachol and thapsigargin (an 
endoplasmic reticulum Ca2+-ATPase inhibitor), both known 
agonists of Ca2+-dependent signaling, to probe the actions 
of nanoparticles on Ca2+-mediated short-circuit current 
responses in Calu-3 cells. Carbachol, a cholinergic agonist 
which causes the release of Ca2+ ions from intracellular 
stores (100 µM basolateral), increased short-circuit current 
by 12.4 ± 0.6 µA/cm2 (peak Isc, data not shown). The sub-
sequent addition of N20 10 µg/mL apical further increased 
the short-circuit current by 57.3 ± 1.8 µA/cm2 (peak Isc), and 
this effect was blocked by BaCl2 5 mM, basolateral a blocker 
of K+ channels, by 30.8 ± 1.0 µA/cm2 (data not shown). International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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On the other hand, in the absence of carbachol, N20 activated 
the short-circuit current by 37.9 ± 5.8 µA/cm2 (peak Isc, 
Figure 5A). Furthermore, the addition of carbachol after 
N20 significantly increased the short-circuit current by 
123 ± 22.6 µA/cm2 (peak Isc, Figure 5A). As expected, 
BaCl2 5 mM, basolateral reduced the short-circuit current by 
29.7 ± 3.8 µA/cm2 (Figure 5A). A summary of the statistical 
analysis is shown in Figure 5B.
To elucidate further the mechanisms by which N20 syner-
gistically increased short-circuit current responses in the pres-
ence of carbachol, we used thapsigargin to investigate if N20 
was affecting Ca2+-dependent cell signaling directly via the 
involvement of intracellular Ca2+ stores. Thapsigargin 1 µM 
bilaterally was found to increase the short-circuit current 
by 16.5 ± 3.6 µA/cm2 in Calu-3 cells (peak Isc,   Figure 5C). 
The subsequent addition of N20 10 µg/mL apical further 
increased the short-circuit current by 53.5 ± 5.2 µA/cm2 
(peak Isc, Figure 5C) and this effect was blocked by furo-
semide 1 mM basolateral, decreasing the stimulated short-
circuit current by 44.5 ± 4.8 µA/cm2, and BaCl2 5 mM 
basolateral transiently reduced the short-circuit current by 
a further 13.3 ± 0.5 µA/cm2. In the absence of thapsigargin, 
N20 activated the short-circuit current by 49.4 ± 3.4 µA/cm2 
(peak Isc, Figure 5D). Furthermore, the addition of thapsi-
gargin after N20 increased the short-circuit current by 
65.8 ± 3.6 µA/cm2 (peak Isc, Figure 5D). Furosemide 1 mM 
basolateral and BaCl2 5 mM basolateral both reduced the 
short-circuit current by 49.4 ± 11.4 and 10.5 ± 0.1 µA/cm2, 
respectively (Figure D). The statistical analysis of results in 
Figures 5C–5D is shown in Figure 5E. Overall, these results 
indicate that N20 can act upon Ca2+-dependent cell signaling 
to drive anion secretion, and that intracellular calcium stores 
may be the source of this cation in Calu-3 cells.
Nanoparticles affect soluble guanylyl 
cyclase-cgMP cell signaling involved in 
anion secretion
The nitric oxide-soluble guanylyl cyclase-cGMP pathway 
is an important pathway for anion secretion in respiratory 
cells.20,24 Therefore, we wanted to investigate the effect 
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of N20 on the short-circuit current in the presence and 
absence of the nitric oxide donor, S-nitrosoglutathione. In 
the absence of S-nitrosoglutathione, N20 10 µg/mL apical 
activated the short-circuit current by 11.8 ± 3.3 µA/cm2 
(peak Isc). In the presence of S-nitrosoglutathione 100 µM 
both sides, N20 increased the short-circuit current by only 
2.4 ± 0.7 µA/cm2 (peak Isc, data not shown). S-nitrosoglu-
tathione-induced short-circuit current responses (peak Isc), 
in the presence and absence of N20, were 39.1 ± 1.6 and 
26.1 ± 2.5 µA/cm2, respectively. These responses were 
found to be significantly different from each other (peak Isc, 
P , 0.05, n = 3, data not shown).
Next, we examined the response of N20 in the presence 
of L-NAME, a nitric oxide synthase inhibitor which inhibits 
the generation of endogenous nitric oxide. The application 
of L-NAME 1 mM both sides caused a transient reduction 
in the basal short-circuit current (Figure 6A). The subse-
quent addition of N20 10 µg/mL apical increased the short-
circuit current by 9.4 ± 1.2 µA/cm2. Finally, the addition of 
diphenylamine-2-carboxylate 1 mM apical and BaCl2 5 mM 
basolateral reduced the short-circuit current by 6.6 ± 0.4 and 
1.3 ± 0.4 µA/cm2, respectively (Figure 6A). This increase 
in short-circuit current as a result of N20 was found not to 
be significantly different from the effects detected in the 
absence of L-NAME (control, P . 0.05, unpaired t-test, 
n = 3). In controls, the short-circuit current was inhibited 
by the addition of diphenylamine-2-carboxylate 1 mM 
apical (5.4 ± 0.2 µA/cm2) and BaCl2 5 mM basolateral 
(1.01 ± 0.3 µA/cm2, Figure 6A).
The effects of nitric oxide on short-circuit current in 
Calu-3 cells are known to be mediated by the activation 
of soluble guanylyl cyclase enzymes through increases in 
cGMP.20,25 To determine whether this pathway was involved in 
short-circuit current activation by N20, Calu-3 cells were pre-
treated with a selective inhibitor of soluble guanylyl cyclase, 
ODQ 10 µM both sides. ODQ caused a transient reduction in 
short-circuit current and prevented the activation of the short-
circuit current by N20 10 µg/mL apical (P , 0.05, unpaired 
t-test, n = 3, Figure 6B). As expected, the short-circuit current 
was inhibited by the addition of diphenylamine-2-carboxylate 
1 mM apical (6.9 ± 1.8 µA/cm2) and BaCl2 5 mM basolateral 
(3.1 ± 0.5 µA/cm2,   Figure 6B). These results indicate that 
soluble guanylyl cyclase and downstream cGMP signaling 
plays a crucial role in N20-mediated short-circuit current 
activation in Calu-3 cells.
excised inside-out patch clamp 
recordings of N20-stimulated CFTr 
activity
Figure 7A shows that the addition of N20 50 µg/mL to the 
bath of the membrane patch activated CFTR Cl- channels 
with a Po value of 0.22 ± 0.031 (n = 3). The channel activity 
could be blocked by 500 µM Au(CN)2
-, ie, a blocker of the 
CFTR channel. Figure 7B shows the stimulation of CFTR 
channels by 20 nM protein kinase A and 1 mM MgATP. The 
subsequent addition of N20 50 µg/mL to the bath further 
increased the channel activity. In other studies, stimulation 
of the cAMP pathway by protein kinase A/MgATP resulted 
in the activation of CFTR channels with Po = 0.07 ± 0.05 
(n = 3). Subsequent addition of N20 50 µg/mL to the bath 
further increased CFTR activity to Po = 0.34 ± 0.09 (P , 0.05, 
paired t-test, n = 3). Control baby hamster kidney cell patches 
lacking expression of wild-type CFTR Cl- channels showed 
no response when stimulated with N20 50 µg/mL (data not 
shown).
Discussion
We investigated a hypothesis that polystyrene nanoparticles 
have the ability to act as modulators of ion channel function 
in human airway epithelial cells. The main novel findings 
of this study were that acute exposure of epithelial cells to 
N20 led to the activation of transepithelial anion transport, 
an effect inhibited by diphenylamine-2-carboxylate, a CFTR 
Cl- channel blocker. The effectiveness of N20 to activate 
CFTR Cl- channels was comparable with that of the cAMP 
elevating agonist, forskolin. N20 activated cAMP-dependent 
basolateral K+ channels and affected three distinct cell sig-
naling systems concerned with ion channel activation in 
respiratory cells, ie, the cAMP, Ca2+, and soluble guanylyl 
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cyclase-cGMP pathways. Our patch clamp studies also show 
the direct activation of single CFTR Cl- channels by N20.
We know that nanoparticle characteristics, including size, 
surface modification, and charge, are major factors influenc-
ing biological interactions with nanomaterials. Such charac-
teristics can exert a profound effect on respiratory tissues, 
and thus be an important criterion for short-circuit current 
activation in Calu-3 cells. Nanoparticle surface modifications 
could influence the affinity of N20 to the plasma membrane. 
Wang et al examined the effects of polystyrene nanoparticles 
on single-component phospholipid bilayers using fluores-
cence and calorimetry experiments after mixing together 
either positively or negatively charged nanoparticles of 
approximately 20 nm in size in suspension with liposomes.26 
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The findings of their study showed that there was surface 
reconstruction where the nanoparticles absorbed onto the 
bilayer membrane, with negatively charged nanoparticles 
inducing local gelation in fluid bilayers and positively charged 
nanoparticles inducing gelled membranes to fluid locally.26 
In 2010, Yang and Ning investigated the interactions between 
charged nanoparticles (positive, negative, and uncharged) and 
charge-neutral phospholipid membranes by coarse-grained 
molecular dynamic simulations.27 Their results were dis-
cussed in terms of free energy, entropy, and enthalpy, where 
they describe an energy barrier existing between lipids and 
charged nanoparticles. They concluded that electrostatic 
attractions help to improve the adhesion of charged nano-
particles to phospholipid membranes, and that increases in 
electrostatic energy can result in charged nanoparticles being 
almost fully wrapped by membrane.27 Chen et al showed 
using whole cell patches that cationic nanoparticles working 
at noncytotoxic concentrations can cause nanoscale defects 
in the plasma membrane of human embryonic kidney and 
human epidermoid carcinoma cells.28 Thus, membrane fluid-
ity may be affected by nanoparticle charge.
Polystyrene nanoparticles have been shown specifically 
to affect processes and membrane structure dynamics on 
airway epithelial cells. Salomon and Ehrhardt showed that 
small carboxylated and sulfated polystyrene nanoparticles 
reduced P glycoprotein-mediated effluxes of Rh123 from 
alveolar airway cells, A549.18 They hypothesized that this 
effect was due to the direct interaction and interference of 
polystyrene nanoparticles with P glycoprotein function. 
Brandenberger et al29 exposed human pulmonary epithelial 
cells to fluorescent polystyrene nanospheres (41 nm) with-
out surface charge modifications. They found that these 
particles induced changes in the apical plasma membrane 
surface area as measured by design-based stereology. They 
concluded that this observed enlargement was dependent 
on particle surface area dose.29 Interestingly, our own data 
show that short-circuit current activation by N20, working 
at noncytotoxic concentrations, occurs in a concentration-
dependent manner in Calu-3 cells. Therefore, nanoparticle–
membrane interactions with   subsequent secondary activation 
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of cell signaling pathways may play an important role in our 
observed effects.
We found that the effects of N20 on CFTR-driven short-
circuit current responses in Calu-3 cells were abolished by 
ODQ, a selective inhibitor of soluble guanylyl cyclase,30 
implicating the soluble guanylyl cyclase-cGMP pathway 
and cGMP-dependent phosphorylation of CFTR Cl- chan-
nels in the actions of N20. Pretreatment of epithelial cells 
with an inhibitor of nitric oxide synthase, ie, l-NAME, did 
not modify the activator effects of N20. Because nitric oxide 
synthase is present and active in Calu-3 cells regulating 
anion secretion,20 these data together indicate that soluble 
guanylyl cyclase, but not nitric oxide synthase-dependent 
responses, are targeted by N20. Our experiments using 
agonists of adenylate (forskolin) and guanylyl (S-nitroso-
glutathione) cyclase showed that prestimulation of either 
system largely abolishes the effects of the nanoparticles. 
Similarly, the inhibition of soluble guanylyl cyclase by 
ODQ abolished nanoparticle-driven short-circuit current 
responses.
There are a number of levels where the cAMP and 
cGMP systems can cross-talk with each other. This includes 
activation of respective protein kinases (A and G) involved 
in channel gating, as well as cGMP-mediated inhibition of 
cAMP breakdown by the family of phosphodiesterases.31 In 
turn, nanoparticle-stimulated increases in cyclic nucleotide 
levels will increase protein kinase-controlled protein phos-
phorylation and the subsequent phosphorylation of sites on 
the regulatory domain of CFTR Cl- channels, which in turn 
will facilitate the exit of Cl- through apically located CFTR 
Cl- channels, an effect supported by an increased bioavail-
ability of Ca2+.20,32
Other groups have also found that nanomaterials can 
affect Ca2+ and cAMP-signaling systems in neuronal and 
fibroblast cell models. Tang et al showed that nanoparticles 
can affect intracellular Ca2+ levels in mammalian cells.33 They 
demonstrated that unmodified cadmium selenium quantum 
dots elevate cytoplasmic calcium levels in primary cultures 
of rat hippocampal neurons. The mechanism for this activa-
tion is still unknown, although the group did identify that the 
increase in cytoplasmic calcium involved both extracellular 
Ca2+ influx and internal Ca2+ release. Also, extracellular 
influx of Ca2+ could only be partially inhibited by a Ca2+ 
channel antagonist (eg, verapamil), whereas internal Ca2+ 
release was abolished by treatment of cells with clonazepam, 
a specific inhibitor of mitochondrial Na+-K+ exchangers, and 
with antrolene, an antagonist of ryanodine receptors in the 
endoplasmic reticulum.33
Many research groups are interested in the manipulation 
of magnetic nanoparticles, such as magnetic tweezers or 
ligand-coated magnetic nanoparticles which are capable of 
mechanical activation of cell receptors.34 Magnetic particles 
used to investigate mechanotransduction, such as integrin-
bound collagen-coated ferric oxide beads, have revealed that 
tension applied on human fibroblasts can cause Ca2+ spikes 
which can modulate cellular functions.35 Meyer et al, using 
suspended bovine endothelial cells and a magnetic twisting 
device demonstrated that, when a controlled twisting (shear) 
stress of 15.6 dyne per cm-2 was applied to ligand-coated 
magnetic microbeads in contact with these cells, cAMP 
production was increased due to adenylyl cyclase activation.36 
Thus, the literature shows that mechanical stress applied to 
the cell surface can alter both Ca2+ and cAMP signaling.
N20 had distinct targets other than CFTR Cl- channels. 
K+ ions are recycled across the basolateral membrane by 
K+ channels which work to maintain the negative potential 
difference of the cell interior. The opening of basolateral K+ 
channels in epithelial cells is an important process for anion 
secretion because it causes the cell to become hyperpolarized 
which, in turn, increases the electrical gradient for Cl- ions to 
exit across the apical surface of the epithelium.37 Our studies 
show that N20 can also activate cAMP-dependent basolateral 
K+ channels. The evidence for this comes from experiments 
which show that N20-activated K+ currents were inhibited by 
XE991, an inhibitor of cAMP-sensitive basolateral K+ chan-
nels, and that the effects of N20 on basolateral K+ currents 
were abolished by pretreating cells with forskolin. It is likely 
that stimulation of cAMP, along with significant cross-talk 
between membrane systems,38 can lead to indirect activation 
of cAMP-regulated K+ channels upon apical exposure of 
Calu-3 cells to N20.
The NKCC1 cotransporter isoform is expressed on the 
basolateral membrane of secretory epithelia, where it acts 
in concert with other transporters and ion channels, such 
as CFTR, basolateral K+ channels, and Na+-K+ pumps, to 
produce transepithelial Cl- secretion. NKCC is expressed 
on virtually all mammalian cells, where it functions to main-
tain cell volume.39 The observed effects of N20 on Cl- and 
HCO3
- transport are most likely indirect consequences of 
short-circuit current activation, eg, the NKCC cotransporter 
is activated to restore intracellular chloride levels due to the 
efflux of Cl- from cells by activated CFTR Cl- channels and, 
in turn, HCO3
- transport is more likely linked to the activa-
tion of basolateral K+ channels.37 Finally, the cyclic forsko-
lin response observed after stimulation of cells with N20 
(Figure 2A) could be the result of Cl- bursts out of the cell International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1355
Polystyrene nanoparticles stimulate airway ion channels
due to the unsynchronized effects of NKCC   cotransporters 
and CFTR Cl- channels working to restore depleted intracel-
lular chloride levels.
We used the inside-out configuration of the patch clamp 
technique because it allowed us to study the interaction 
of nanoparticles with the intracellular domains of CFTR 
Cl- channels. No other research group to our knowledge has 
investigated the effect of nanoparticles on ion channel func-
tion using this configuration of the technique. In 2009, Zhao 
et al showed using the whole cell patch clamp technique that 
zinc nanoparticles enhanced the current amplitudes of sodium 
and potassium by a mechanism mainly relying on increasing 
the opening number of sodium channels and delaying rectifier 
potassium channels.40 Overall, that study showed that zinc 
nanoparticles have the ability to affect ionic homeostasis and 
physiological processes in rat hippocampal CA3 pyramidal 
neurons. We have shown in baby hamster kidney cells that 
N20 can directly activate CFTR Cl- channels both in the 
presence and absence of ATP and protein kinase A. Studies 
using nucleotide binding domain mutants of CFTR Cl- chan-
nels, such as G551D and G1349D, demonstrate that most 
CFTR activators have decreased affinity for activating mutant 
CFTR Cl- channels.41 Therefore, putative binding sites 
on the nucleotide-binding domains of CFTR Cl- channels 
are proposed to be target(s) for many CFTR activators.42,43 
However, our data indicate that the primary mechanism of 
single CFTR Cl- channel activation by N20 may not involve 
the nucleotide-binding domains or regulatory domain of 
CFTR, because these sites have been previously stimulated 
by ATP and protein kinase A. Therefore, we cannot rule out 
the possibility that N20 may in some way influence structural 
changes in the transmembrane domains of CFTR Cl- chan-
nels, resulting in channel activation.
Altogether, our data demonstrate that polystyrene nanopar-
ticles can affect processes at the plasma membrane on airway 
epithelial cells specifically with regard to ion channel function 
and ionic homeostasis. Furthermore, once inside airway cells, 
our patch clamp data demonstrate that polystyrene nanopar-
ticles could potentially affect CFTR Cl- channel function 
directly. This is an exciting observation because it gives us an 
insight as to how nanoparticles might behave once inside the 
cell. More experimental data is needed to clarify the precise 
sequence of molecular events following the exposure of epi-
thelial cells to nanoparticles and also the interesting data that 
reveal the selectivity for the stimulation of cAMP-regulated 
K+ channels in comparison with Ca2+-regulated ones on the 
basolateral membrane. Finally, experimental validation with 
regard to other nanoparticle types, eg, silica, titanium, and zinc, 
would have to be done in future studies to establish if NP 
composition is an important factor underlying the ability of 
polystyrene nanoparticles to activate CFTR Cl- channels and 
affect ion transport in airway epithelial cells.
Conclusion
Our studies demonstrate that polystyrene nanoparticles 
cannot be considered as a simple neutral vehicle for drug 
delivery. Polystyrene nanoparticles in the respiratory system 
may influence cell signaling systems (cyclic nucleotide and 
calcium) as a result of nanoparticle-membrane   interactions. 
Finally, after endocytosis by epithelial cells lining the air-
ways, polystyrene nanoparticles have the potential to interact 
directly with ion channels such as CFTR.
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